Volvit is a vitamin preparation that affects metabolic processes.
Release form and composition
Make Volvit tablets, coated. The active ingredient of the drug is biotin (5 mg per 1 tablet). Auxiliary substances are sodium lauryl sulfate, celactose 80, croscarmellose sodium, colloidal silicon dioxide, magnesium stearate.
In blister packs of 10 tablets.
Indications for use
According to the instructions, Volvit is indicated for use as a prophylactic or therapeutic agent for conditions caused by a lack of biotin, namely:
- Skin diseases (dysfunction of the sebaceous glands, dermatitis, violation of the keratinization processes of the skin);
- Diseases of the nails (change in the structure of the nail plate, impaired growth of nails)
- Hair diseases (hair loss, pigmentation disturbance (gray hair), seborrhea of the scalp, dandruff, impaired growth and hair structure);
- Hereditary pathologies associated with impaired biotinidase metabolism;
- Diseases or functional changes in the digestive system, malabsorption syndrome;
- Violations of psycho-emotional background.
According to the instructions, Volvit is contraindicated only in case of individual intolerance to the main or auxiliary components of the drug.
Do not apply Volvit for the treatment of children under 12 years of age.
Dosing and Administration
Volvit is used once a day before meals with a half cup of water. The average daily therapeutic dosage of a vitamin preparation is 5 mg (1 tablet). With malabsorption syndrome, hereditary pathologies associated with disorders of biotinidase metabolism, Volvit is allowed to use in the amount of 10 mg (2 tablets) per day.
In case of multiple carboxylase deficiency, Volvit is prescribed at a dose of 20 mg per day.
The duration of therapy with a vitamin preparation is 1 month.
The use of Volvit by patients is well tolerated, the side effects are mainly caused by biotin intolerance. The most common side effects are:
- Skin eruption;
- Chest pains;
- Allergic edematous process of the laryngeal mucosa (requires immediate treatment to the hospital).
During the period of pregnancy and lactation, Volvit is not recommended, except for strict indications.
The combined use of Volvit and anticonvulsants can cause a decrease in the level of biotin in the blood due to the acceleration of its withdrawal from the body.
The assimilation of the active component of a vitamin preparation is inhibited by drugs based on valproic acid.
Vitamin B5 (pantothenic acid) competitively interacts with biotin, reducing its effectiveness. Therefore, in the case of simultaneous administration of these drugs, they should be taken at different time intervals.
Excessive intake of raw egg white during the administration of Volvit suppresses biotin bioavailability. This is due to the fact that avidin is present in the composition of the egg white, which forms a strong bond with biotin, thereby disrupting its absorption.
Volvit is intended only for long-term use. The effectiveness of therapy decreases with its irregular admission or interruption of the course.
The use of alcoholic beverages during Volvit therapy reduces the therapeutic effect.
Cases of overdose Volvita today not recorded.
Structural analogues of Volvit are:
Terms and conditions of storage
Volvit from pharmacies dispensed without a doctor's prescription. Vitamin preparation is stored in a dry, cool, dark and inaccessible for children place no longer than two years from the date of issue.